By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Algeta AS 

Kjelsasveien 172 A
P.O. Box 54 Kjelsas
Oslo    NO-0411  Norway
Phone: 47-23-00-79-90 Fax: 47-23-00-79-91


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Bayer AG (BAYN.DE) Clinches $2.9 Billion Deal For Norway's Algeta 2/24/2014 7:14:33 AM
Algeta Release: Net Sales of Xofigo (radium Ra 223 dichloride) Injection for Third Quarter 2013 10/31/2013 12:54:27 PM
Algeta Release: New Data and Analyses From the Phase 3 ALSYMPCA Trial of Xofigo® (Radium Ra 223 Dichloride) Injection to be Presented at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013 9/12/2013 9:36:33 AM
Algeta Schedules First Half and Second Quarter 2013 Results Presentation, Webcast and Conference Call 8/19/2013 9:22:03 AM
Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer 8/19/2013 9:20:45 AM
Algeta Celebrates the Official Opening of Its Commercial Production Facility for Xofigo® (Radium Ra 223 Dichloride) Injection at the Institute for Energy Technology (IFE) in Norway 6/21/2013 10:22:35 AM
Algeta: New Data and Analyses From Clinical Trials of Xofigo(R) (Radium Ra 223 Dichloride) to be Presented at American Society of Clinical Oncology 5/17/2013 10:34:30 AM
Algeta Results for the First Quarter 2013 5/15/2013 10:58:15 AM
Bayer AG (BAY.F), Algeta Win FDA Approval for Prostate Cancer Drug 5/15/2013 10:05:10 AM
Algeta Schedules First Quarter 2013 Results Presentation, Webcast and Conference Call 5/7/2013 10:20:30 AM
1234
//-->